Andrea Montabone

P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

Ovidio De Filippo, Fabrizio D’Ascenzo, Sergio Raposeiras‐Roubín et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2019 · 51 citations · Full text

Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries

Fabrizio D’Ascenzo, Carloalberto Biolè, Sergio Raposeiras‐Roubín et al. · American Heart Journal · 2019 · 39 citations · Full text

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +9

Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor

Matteo Bianco, Fabrizio D’Ascenzo, Sergio Raposeiras‐Roubín et al. · International Journal of Cardiology · 2019 · 35 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Epidemiology +13

Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry

Fabrizio D’Ascenzo, Maurizio Bertaina, Francesco Fioravanti et al. · European Journal of Preventive Cardiology · 2019 · 34 citations

Cerebral protection in left atrial appendage closure in the presence of appendage thrombosis

Giacomo Boccuzzi, Andrea Montabone, Fabrizio D’Ascenzo et al. · Catheterization and Cardiovascular Interventions · 2020 · 29 citations